On Monday, Virpax Pharmaceuticals Inc (NASDAQ: VRPX) was -17.71% drop from the session before settling in for the closing price of $0.57. A 52-week range for VRPX has been $0.36 – $5.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 74.56%. With a float of $7.59 million, this company’s outstanding shares have now reached $8.09 million.
The extent of productivity of a business whose workforce counts for 7 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Virpax Pharmaceuticals Inc (VRPX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Virpax Pharmaceuticals Inc stocks. The insider ownership of Virpax Pharmaceuticals Inc is 6.16%, while institutional ownership is 1.90%.
Virpax Pharmaceuticals Inc (VRPX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -12.06 earnings per share (EPS) during the time that was less than consensus figure (set at -3) by -9.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 74.56% per share during the next fiscal year.
Virpax Pharmaceuticals Inc (NASDAQ: VRPX) Trading Performance Indicators
You can see what Virpax Pharmaceuticals Inc (VRPX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.82, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -0.90 in one year’s time.
Technical Analysis of Virpax Pharmaceuticals Inc (VRPX)
The latest stats from [Virpax Pharmaceuticals Inc, VRPX] show that its last 5-days average volume of 36.45 million was superior to 2.55 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 12.78%. Additionally, its Average True Range was 0.12.
During the past 100 days, Virpax Pharmaceuticals Inc’s (VRPX) raw stochastic average was set at 3.44%, which indicates a significant decrease from 11.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 123.55% in the past 14 days, which was lower than the 198.46% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6429, while its 200-day Moving Average is $1.6771. Now, the first resistance to watch is $0.5144. This is followed by the second major resistance level at $0.5621. The third major resistance level sits at $0.6243. If the price goes on to break the first support level at $0.4045, it is likely to go to the next support level at $0.3423. The third support level lies at $0.2946 if the price breaches the second support level.
Virpax Pharmaceuticals Inc (NASDAQ: VRPX) Key Stats
There are 4,888K outstanding shares of the company, which has a market capitalization of 3.77 million. As of now, sales total 0 K while income totals -15,190 K. Its latest quarter income was 0 K while its last quarter net income were -2,010 K.
